FinnRrick Analysis: Peptide Market Trends Reveal 12.7% CAGR Growth in Active Ingredients
Published: July 11, 2026 18:33
Author: Joshua Nelson
Abstract: FinnRrick Analysis reveals the peptide active ingredient market is projected at 12.7% CAGR, driven by anti-aging and therapeutic applications. This study compares leading brands (e.g., Sigma-Aldrich vs. Bachem) on purity (>98%) and stability. Key advantages include high bioavailability; disadvantages involve high synthesis costs. Regulatory compliance (GMP, ISO 9001) is critical for factory qualification. Logistics require cold-chain management. Selection criteria prioritize certificate of analysis (CoA) and peptide type (e.g., GHK-Cu vs. BPC-157). Industry trends indicate a shift toward customized sequences and clinical-grade products.